Canada markets close in 3 hours 14 minutes

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7050+0.0650 (+2.46%)
As of 12:46PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close2.6400
Open2.5900
Bid2.6500 x 1800
Ask2.6600 x 900
Day's Range2.5900 - 2.7600
52 Week Range1.7100 - 14.4200
Volume367,956
Avg. Volume865,396
Market Cap197.484M
Beta (5Y Monthly)0.41
PE Ratio (TTM)N/A
EPS (TTM)-1.5440
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.33
  • GlobeNewswire

    Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    EMERYVILLE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that the company’s Board of Directors granted three employees nonqualified stock options to purchase an aggregate of 12,400 shares of its common stock with an exercise price of $3.59, which is equal to the closing price of Gritstone’s common stock on September 9, 2022, the last trading day precedin

  • GlobeNewswire

    Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022

    -- SLATE vaccines (version 1 and SLATE-KRAS) demonstrate early evidence of efficacy with a 39% molecular response rate in evaluable patients with late-line microsatellite-stable colorectal cancer (MSS-CRC) and non-small cell lung cancer (NSCLC) -- -- Molecular response, as measured by reduction in circulating tumor DNA (ctDNA) from baseline, demonstrates a correlation with overall survival (OS) in NSCLC, consistent with industry literature -- -- SLATE-KRAS vaccine candidate elicits robust KRAS n

  • GlobeNewswire

    Gritstone to Participate in Two Upcoming Investor Conferences

    EMERYVILLE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that management will present at the 2022 Wells Fargo Healthcare Conference, taking place September 7-9, 2022, in Boston, MA, and participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022, in New York, NY. The events will also